MDMA
Synthesis Route
The dominant route is reductive amination of safrole (or its precursors PMK, MDP2P) with methylamine and a reducing agent (aluminum amalgam or sodium borohydride). Safrole derives from sassafras oil. Cartel-scale production now uses synthetic PMK precursors.
Predictable Synthesis Byproducts
- PMK - incomplete reduction leaves traces of starting material.
- MDA - the demethylated cousin of MDMA. Often present in trace amounts; sometimes deliberately enriched.
- Aluminum salts - when aluminum amalgam reduction is used.
- Solvent residues - toluene, methanol, hydrochloric acid.
Typical Adulterants
MDMA is one of the most adulterated drugs in the supply. The relevant probability is not just "what's mixed in" but whether it's even MDMA at all.
Baseline estimate: roughly a 1-in-2 chance a street "MDMA" sample is pure MDMA, and a meaningful chance it contains no MDMA whatsoever. (Palamar et al., 2024; EcstasyData/DanceSafe 2010–2024; data current as of 2024; prevalence figures shift year-to-year)
| Adulterant | Est. probability | Why it matters |
|---|---|---|
Synthetic cathinones"bath salts" - methylone, ethylone, eutylone, pentylone, alpha-PVP |
Moderate–high | Most common MDMA adulterant class over the past decade (Brunt et al., 2017). Higher cardiovascular risk than MDMA; longer duration; can cause psychosis. Marquis reagent turns dark, falsely indicating MDMA. |
Caffeine |
Moderate | Masks weak content; cardiac stress at high doses |
Methamphetamine |
Low–moderate | Pure stimulant load, no empathogenic effect |
2C-B, 2C-Iphenethylamine psychedelics |
Low | Psychedelic, not empathogenic; higher dose-sensitivity |
DXMdissociative |
Low | Dissociative effects; serotonin syndrome risk with SSRIs |
PMA / PMMA"death amphetamine" |
Low | Slow onset (1–2 hrs) → user redoses → sudden hyperthermia and serotonin syndrome. Low probability, lethal outcome. |
Fentanyl |
Very low | Documented but rare in MDMA. Lethal in opioid-naive users. |
Removal & Testing
MDMA cannot be re-purified once cut. Synthetic cathinones are chemically similar enough that they cannot be separated without lab equipment.
Reagent testing is essential and accessible. Use reagents in series to identify adulteration:
| Reagent | MDMA result | Cathinone result | What it confirms |
|---|---|---|---|
| Marquis | Purple/black | Yellow/orange | Presence of MDMA class |
| Mecke | Blue-green | Brown/yellow | Distinguishes from cathinones |
| Mandelin | Black | Variable | Secondary confirmation |
| Simon's | Blue | No reaction | Confirms secondary amine (rules out MDA) |
A sample that turns dark on Marquis but yellow on Mecke is likely a cathinone, not MDMA. Use reagents in series; one kit is not enough.
Fentanyl test strips are recommended despite low fentanyl probability, because of consequence. Quantitative mail-in services (DrugsData/EcstasyData, Energy Control, DIMS) give actual mg content.
Sources: Full references for the citations in this submodule (Palamar et al., 2024; Brunt et al., 2017; Lambdin et al., 2023; EcstasyData/DanceSafe, 2010–2024) are listed in the Module 10 Sources section.